PH30702A - Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1yl-compounds. - Google Patents

Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1yl-compounds.

Info

Publication number
PH30702A
PH30702A PH47242A PH47242A PH30702A PH 30702 A PH30702 A PH 30702A PH 47242 A PH47242 A PH 47242A PH 47242 A PH47242 A PH 47242A PH 30702 A PH30702 A PH 30702A
Authority
PH
Philippines
Prior art keywords
compounds
disturbances
pharmaceutical compositions
compositions containing
treating colon
Prior art date
Application number
PH47242A
Other languages
English (en)
Inventor
Eeckout Christian
Preuschoff Ulf
David Samuel
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of PH30702A publication Critical patent/PH30702A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH47242A 1992-11-14 1993-11-11 Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1yl-compounds. PH30702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
PH30702A true PH30702A (en) 1997-09-16

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
PH47242A PH30702A (en) 1992-11-14 1993-11-11 Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1yl-compounds.

Country Status (24)

Country Link
US (1) US5438068A (fr)
EP (1) EP0601345B1 (fr)
JP (1) JP3683286B2 (fr)
KR (1) KR100266715B1 (fr)
CN (1) CN1041053C (fr)
AT (1) ATE143597T1 (fr)
AU (1) AU667243B2 (fr)
CA (3) CA2538177A1 (fr)
CZ (1) CZ284154B6 (fr)
DE (2) DE4238553A1 (fr)
DK (1) DK0601345T3 (fr)
DZ (1) DZ1726A1 (fr)
ES (1) ES2092206T3 (fr)
GR (1) GR3021230T3 (fr)
HK (1) HK1006537A1 (fr)
HU (1) HU213506B (fr)
IL (1) IL107454A (fr)
MX (1) MX9307079A (fr)
NO (1) NO303926B1 (fr)
NZ (1) NZ250103A (fr)
PH (1) PH30702A (fr)
RU (1) RU2125877C1 (fr)
SK (1) SK278874B6 (fr)
ZA (1) ZA938463B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (fr) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH Dérivés 4-hydroxy de 5,6,9,10-tetrahydro-10-((2-méthyl-1h-imidazol-1-yl)méthyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
EP1558081A4 (fr) * 2003-01-13 2006-06-14 Dynogen Pharmaceuticals Inc Methode de traitement de troubles intestinaux fonctionnels
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
EP0297651B1 (fr) * 1987-06-29 1993-11-03 Duphar International Research B.V Dérivés d'indole annulaires

Also Published As

Publication number Publication date
HK1006537A1 (en) 1999-03-05
NO934090D0 (no) 1993-11-12
US5438068A (en) 1995-08-01
HUT65978A (en) 1994-08-29
DE59304045D1 (de) 1996-11-07
DZ1726A1 (fr) 2002-02-17
GR3021230T3 (en) 1997-01-31
JPH06211656A (ja) 1994-08-02
CZ284154B6 (cs) 1998-08-12
DE4238553A1 (de) 1994-05-19
JP3683286B2 (ja) 2005-08-17
HU213506B (en) 1997-07-28
AU667243B2 (en) 1996-03-14
ES2092206T3 (es) 1996-11-16
EP0601345A1 (fr) 1994-06-15
CZ236593A3 (en) 1994-05-18
IL107454A0 (en) 1994-02-27
ZA938463B (en) 1994-08-01
EP0601345B1 (fr) 1996-10-02
RU2125877C1 (ru) 1999-02-10
SK278874B6 (sk) 1998-04-08
NO303926B1 (no) 1998-09-28
MX9307079A (es) 1994-05-31
DK0601345T3 (da) 1996-11-18
KR100266715B1 (ko) 2000-09-15
CN1092650A (zh) 1994-09-28
CA2504502A1 (fr) 1994-05-15
NO934090L (fr) 1994-05-16
IL107454A (en) 1999-12-22
CN1041053C (zh) 1998-12-09
AU5064393A (en) 1994-05-26
CA2538177A1 (fr) 1994-05-15
ATE143597T1 (de) 1996-10-15
KR940010999A (ko) 1994-06-20
CA2102960A1 (fr) 1994-05-15
SK123593A3 (en) 1994-09-07
CA2102960C (fr) 2005-08-02
NZ250103A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
AU641772B2 (en) Novel anti-epileptics
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
DE69021176D1 (de) Polypeptid und Verfahren zu dessen Herstellung.
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
PH30702A (en) Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1yl-compounds.
GB2269589B (en) 3-Hydroxy-pyridin-4-ones and their use in pharmaceutical compositions
MY113062A (en) Amide derivatives and their therapeutic use
ES2006619A6 (es) Un metodo para preparar derivados de piridil-y pirimidil-piperazinas.
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
TW261605B (fr)
ES8401488A1 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
ZA9610040B (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds.
ES8506643A1 (es) Procedimiento para la preparacion de derivados d,l-, d-y l-del acido 3-imidazolil-2-amino-propionico
IT1254544B (it) Derivato di l-verbenone e composizioni farmaceutiche che lo contengono
MX9605208A (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2103232A1 (es) Nuevos compuestos derivados de 1h-imidazol-2-metanol.